• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Organosilicon compounds Alkylsilanes

Recent Advances in the Application of (5-aminopent-1-yn-1-yl)trimethylsilane (CAS: 154188-73-5) in Chemical Biology and Pharmaceutical Research

The compound (5-aminopent-1-yn-1-yl)trimethylsilane (CAS: 154188-73-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its terminal alkyne and amine functionalities, serves as a versatile building block in organic synthesis and bioconjugation strategies. Recent studies have highlighted its potential in the development of novel therapeutics, diagnostic tools, and chemical probes for biological systems.

One of the most notable applications of (5-aminopent-1-yn-1-yl)trimethylsilane is its role in click chemistry, particularly in copper-catalyzed azide-alkyne cycloaddition (CuAAC) reactions. The terminal alkyne group facilitates efficient conjugation with azide-containing molecules, enabling the synthesis of complex biomolecules with high specificity. Recent research has demonstrated its utility in the labeling of proteins, nucleic acids, and small molecules, thereby enhancing the study of biological processes at the molecular level.

In the context of drug discovery, (5-aminopent-1-yn-1-yl)trimethylsilane has been employed as a key intermediate in the synthesis of pharmacologically active compounds. For instance, it has been used to develop novel kinase inhibitors and antimicrobial agents. A 2023 study published in the Journal of Medicinal Chemistry reported the successful incorporation of this compound into a series of potent inhibitors targeting tyrosine kinases, which are implicated in various cancers. The study underscored the compound's role in improving the pharmacokinetic properties of the inhibitors, such as solubility and bioavailability.

Beyond its applications in drug development, (5-aminopent-1-yn-1-yl)trimethylsilane has also been explored in the field of chemical biology for the design of activity-based probes (ABPs). These probes enable the real-time monitoring of enzyme activity in living systems, providing valuable insights into disease mechanisms. A recent study in ACS Chemical Biology utilized this compound to develop a probe for detecting caspase activity, a critical mediator of apoptosis. The probe exhibited high sensitivity and selectivity, making it a promising tool for studying programmed cell death in cancer research.

Despite its promising applications, challenges remain in the large-scale synthesis and handling of (5-aminopent-1-yn-1-yl)trimethylsilane. Researchers have noted the need for optimized protocols to ensure reproducibility and safety, particularly given the compound's reactive alkyne moiety. Recent advancements in synthetic methodologies, such as flow chemistry, have shown potential in addressing these challenges, offering more efficient and scalable routes for its production.

In conclusion, (5-aminopent-1-yn-1-yl)trimethylsilane (CAS: 154188-73-5) represents a valuable tool in chemical biology and pharmaceutical research. Its versatility in bioconjugation, drug discovery, and probe development underscores its importance in advancing our understanding of biological systems and therapeutic interventions. Future research should focus on overcoming synthetic challenges and expanding its applications in emerging areas such as targeted drug delivery and personalized medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)